Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Scynexis, Inc. names for other drugs.
Recalls
- Sep 25, 2023 · Class I · Scynexis, Inc.
Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).
Lots: Lot# LF21000008, Exp. 11/30/2023 Lot# LF22000051, Exp. 11/30/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ibrexafungerp: every company that makes it
- Form
- tablet, film coated
- Strength
- 150 mg
- Approval
- NDA NDA214900
- On the market since
- Jul 1, 2021
- Package NDCs
75788-115-04- Official label
- DailyMed (National Library of Medicine), updated Nov 4, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?